Natera (NTRA) Interest Coverage Ratio: History & Chart

Natera, Inc.(NTRA)

Medical - Diagnostics & Research · Austin, TX

$410.35+1.88 (+0.46%)

Delayed quote: Oct 2, 2026, 4:00 PM EDT

About Natera, Inc.

Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.

Austin, TX

6,138 employees

www.natera.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: Steven Leonard Chapman

View full financials

NTRA Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-76.16x

INTEREST COVERAGE RATIO AVG TTM

-78.76x

INTEREST COVERAGE RATIO AVG 3Y

-51.49x

INTEREST COVERAGE RATIO AVG 5Y

-54.50x

INTEREST COVERAGE RATIO AVG 10Y

-40.00x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+3.31%

CURRENT VS 3Y AVG

-47.90%

CURRENT VS 5Y AVG

-39.74%

CURRENT VS 10Y AVG

-90.42%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.80x

median of 88 covered companies

CURRENT VS SECTOR MEDIAN

-1220.00%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Natera, Inc. (NTRA)	$58.77B	-76.16x	-78.76x	-51.49x	-54.50x
Cencora, Inc. (COR)vs ›	$60.13B	8.69x	10.46x	10.41x	11.51x
Boston Scientific Corporation (BSX)vs ›	$63.32B	11.38x	9.10x	7.54x	6.16x
Cardinal Health, Inc. (CAH)vs ›	$53.47B	7.51x	9.04x	12.85x	10.81x
Edwards Lifesciences Corporation (EW)vs ›	$49.03B	N/A	75.36x	70.16x	63.82x
Becton, Dickinson and Company (BDX)vs ›	$48.72B	4.21x	4.38x	4.79x	4.28x
Agilent Technologies, Inc. (A)vs ›	$47.38B	13.21x	14.36x	15.54x	14.94x
Humana Inc. (HUM)vs ›	$46.63B	2.30x	2.38x	5.10x	7.90x
Cigna Corporation (CI)vs ›	$71.48B	6.61x	6.58x	6.49x	6.37x
Teva Pharmaceutical Industries Limited (TEVA)vs ›	$46.04B	2.35x	2.35x	1.39x	1.57x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Natera, Inc. (NTRA)

$58.77B

-76.16x

-78.76x

-51.49x

-54.50x

Cencora, Inc. (COR)vs ›

$60.13B

8.69x

10.46x

10.41x

11.51x

Boston Scientific Corporation (BSX)vs ›

$63.32B

11.38x

9.10x

7.54x

6.16x

Cardinal Health, Inc. (CAH)vs ›

$53.47B

7.51x

9.04x

12.85x

10.81x

Edwards Lifesciences Corporation (EW)vs ›

$49.03B

N/A

75.36x

70.16x

63.82x

Becton, Dickinson and Company (BDX)vs ›

$48.72B

4.21x

4.38x

4.79x

4.28x

Agilent Technologies, Inc. (A)vs ›

$47.38B

13.21x

14.36x

15.54x

14.94x

Humana Inc. (HUM)vs ›

$46.63B

2.30x

2.38x

5.10x

7.90x

Cigna Corporation (CI)vs ›

$71.48B

6.61x

6.58x

6.49x

6.37x

Teva Pharmaceutical Industries Limited (TEVA)vs ›

$46.04B

2.35x

1.39x

1.57x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Natera, Inc. (NTRA)?

The interest coverage ratio for NTRA stock is -76.16x.

Is Natera, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of -76.16x is 40% below its 5-year average of -54.50x, near the low end of its 5-year range (-107.26x–-3.19x).

What is the TTM average interest coverage ratio for Natera, Inc. (NTRA)?

The TTM average interest coverage ratio for NTRA stock is -78.76x.

What is the 3Y average interest coverage ratio for Natera, Inc. (NTRA)?

The 3Y average interest coverage ratio for NTRA stock is -51.49x.

What is the 5Y average interest coverage ratio for Natera, Inc. (NTRA)?

The 5Y average interest coverage ratio for NTRA stock is -54.50x.

What is the 10Y average interest coverage ratio for Natera, Inc. (NTRA)?

The 10Y average interest coverage ratio for NTRA stock is -40.00x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	-85.16x
2026-03-31	-104.84x
2025-12-31	-3.19x
2025-09-30	-93.37x
2025-06-30	-107.26x
2025-03-31	-78.78x
2024-12-31	-50.11x
2024-09-30	-12.52x
2024-06-30	-14.04x
2024-03-31	-23.79x
2023-12-31	-26.85x
2023-09-30	-34.13x
2023-06-30	-35.39x
2023-03-31	-45.18x
2022-12-31	-51.52x
2022-09-30	-51.10x
2022-06-30	-66.55x
2022-03-31	-65.71x
2021-12-31	-67.18x
2021-09-30	-72.28x
2021-06-30	-55.56x
2021-03-31	-30.40x
2020-12-31	-17.16x
2020-09-30	-13.06x
2020-06-30	-12.79x
2020-03-31	-14.15x
2019-12-31	-13.51x
2019-09-30	-7.89x
2019-06-30	-10.52x
2019-03-31	-11.65x
2018-12-31	-10.83x
2018-09-30	-9.77x
2018-06-30	-10.63x
2018-03-31	-12.77x
2017-12-31	-19.24x
2017-09-30	-16.96x
2017-06-30	-124.02x
2017-03-31	-202.36x
2016-12-31	-251.42x
2016-09-30	-182.57x
2016-06-30	-184.55x
2016-03-31	-83.52x
2015-12-31	-152.18x
2015-09-30	-17.62x
2015-06-30	-10.15x
2015-03-31	-2.23x
2014-12-31	1.83x
2014-09-30	3.98x
2014-06-30	-1.29x
2014-03-31	-4.51x

DATE

INTEREST COVERAGE RATIO

2026-06-30

-85.16x

2026-03-31

-104.84x

2025-12-31

-3.19x

2025-09-30

-93.37x

2025-06-30

-107.26x

2025-03-31

-78.78x

2024-12-31

-50.11x

2024-09-30

-12.52x

2024-06-30

-14.04x

2024-03-31

-23.79x

2023-12-31

-26.85x

2023-09-30

-34.13x

2023-06-30

-35.39x

2023-03-31

-45.18x

2022-12-31

-51.52x

2022-09-30

-51.10x

2022-06-30

-66.55x

2022-03-31

-65.71x

2021-12-31

-67.18x

2021-09-30

-72.28x

2021-06-30

-55.56x

2021-03-31

-30.40x

2020-12-31

-17.16x

2020-09-30

-13.06x

2020-06-30

-12.79x

2020-03-31

-14.15x

2019-12-31

-13.51x

2019-09-30

-7.89x

2019-06-30

-10.52x

2019-03-31

-11.65x

2018-12-31

-10.83x

2018-09-30

-9.77x

2018-06-30

-10.63x

2018-03-31

-12.77x

2017-12-31

-19.24x

2017-09-30

-16.96x

2017-06-30

-124.02x

2017-03-31

-202.36x

2016-12-31

-251.42x

2016-09-30

-182.57x

2016-06-30

-184.55x

2016-03-31

-83.52x

2015-12-31

-152.18x

2015-09-30

-17.62x

2015-06-30

-10.15x

2015-03-31

-2.23x

2014-12-31

1.83x

2014-09-30

3.98x

2014-06-30

-1.29x

2014-03-31

-4.51x

Interest Coverage Ratio: -76.16x

NTRA Interest Coverage Ratio

NTRA Average Interest Coverage Ratio Chart

NTRA Current vs Average Interest Coverage Ratio Chart

NTRA Interest Coverage Ratio Metrics

NTRA Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

NTRA Interest Coverage Ratio History

Related Metrics